from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1601/hisB

LFCtreatmentdescriptionclass of inhibitor

-0.973

Amikacinug/mL Amikacintranslation

-0.583

Cap5-10ug/mL Capreomycintranslation

-1.900

Rox10-50 ug/mL Roxithromycintranslation

0.140

SM2-5 ug/mL Streptomycintranslation

-2.211

Tet5-10 ug/mL Tetracyclinetranslation

-0.271

Rif0.2-5ug/mL Rifampicintranscription

-0.512

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.651

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.031

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.369

CPZ10-50 ug/mL Chlorpromazinerespiration

0.258

Clofazimine10-13 ug/mL Clofaziminerespiration

0.195

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.103

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.816

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.067

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.040

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.314

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.548

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.992

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.164

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.103

KCN5-20 ug/mL Potassium cyaniderespiration

0.108

NaN30.2-2 mM Sodium aziderespiration

0.283

Nigericin50 uM Nigericinrespiration

-0.129

TRC10-150 ug/mL Triclosanrespiration

0.808

TRZ10-25 ug/mL Thioridazinerespiration

0.736

Valinomycin0.5-10 uM Valinomycinrespiration

1.302

ZnSO42 mM ZnSO4respiration

1.133

menadione6-10 ug/mL Menadionerespiration

-0.397

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.317

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.839

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.389

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.878

NRP_1Non-replicating persistence stage 1dosRassociated

-0.426

Amp0.2mg/mL AmpicillincellWall

-0.123

Cephalexin20-100 ug/mL CephalexincellWall

-0.053

Cerulenin0.32-5 ug/mL CerulenincellWall

0.037

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.095

EMB10-20 ug/mL EthambutolcellWall

-0.036

Eta12-40 ug/mL EthionamidecellWall

-0.458

INH0.2-0.4 ug/mL IsoniazidcellWall

0.373

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.476

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.033

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.198

BZA0.12 mg/mL BenzamidearomaticAmides

-0.168

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.431

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.624

H2O24 mM hydrogen peroxideDNAdamaging

-0.218

Levo10 ug/mL LevofloxacinDNAdamaging

-0.438

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.994

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.069

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.434

UVUV-irradiationDNAdamaging

-0.055

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.036

Antimycin12.5-50 ug/mL Antimycin A?

-0.042

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

0.127

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.950

PA8240.2-2 ug/mL PA-824?

1.892

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.471

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.020

Verapamil50 uM Verapamil?

0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

0.075

methoxatin10-20 ug/mL Methoxatin?